dr. simeone on impact of parp inhibitors on pancreatic cancer
Published 4 years ago • 93 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:57
dr. simeone on the importance of germline testing in pancreatic cancer
-
0:47
dr. richards on parp inhibition in pancreatic cancer
-
1:27
dr. simeone on emerging subtypes of pancreatic cancer
-
1:59
dr. o’reilly on the utility of parp inhibitors in pancreatic cancer
-
1:39
dr. simeone on selecting patients with pancreatic cancer for neoadjuvant therapy
-
0:57
dr. richards on using parp inhibitors in mutated metastatic pancreatic cancer
-
1:26
dr. simone discusses the precision promise trial in pancreatic cancer
-
1:16
dr. simeone discusses unmet needs in pancreatic cancer
-
5:02
parp inhibitors in pancreatic cancer
-
1:25
dr. mizrahi on addition of parp inhibitors to chemotherapy in mutated pancreatic cancer
-
5:53
adverse-effect profiles of parp inhibitors in ovarian cancer
-
0:58
dr. crafton on the impact of parp inhibitors in recurrent ovarian cancer
-
30:35
dr. simeone - targeting pancreatic cancer stem cells
-
1:48
dr. chung on sequencing chemotherapy regimens in metastatic pancreatic cancer
-
0:50
dr. secord on the role of parp inhibitors in ovarian cancer
-
0:31
copy of dr. chung on sequencing chemotherapy regimens in metastatic pancreatic cancer
-
1:22
dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
-
3:44
the future role of parp inhibition in ovarian cancer
-
0:58
dr. o’malley on the optimal use of parp inhibitors in advanced ovarian cancer